<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940705-2-00151</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix Q-II-B&hyph;1-a-(3). The containment building shall be controlled and have  <!-- PJG 0012 frnewline --> a locking access.  <!-- PJG 0012 frnewline --> Appendix Q-II-B&hyph;1-a-(4). The Animal Facility Director shall establish policies and  <!-- PJG 0012 frnewline --> procedures whereby only persons who have been advised of the potential hazard  <!-- PJG 0012 frnewline --> and who meet any specific entry requirements (e.g., vaccination) may enter the  <!-- PJG 0012 frnewline --> laboratory or animal rooms.  <!-- PJG 0012 frnewline --> Appendix Q-II-B&hyph;1-a-(5). Animals of the same or different species, which are not  <!-- PJG 0012 frnewline --> involved in the work being performed, shall not be permitted in the animal area.  <!-- PJG 0012 frnewline --> Appendix Q-II-B&hyph;1-b. Decontamination and Inactivation (BL2&hyph;N)  <!-- PJG 0012 frnewline --> Appendix Q-II-B&hyph;1-b-(1). Contaminated materials that are decontaminated at a  <!-- PJG 0012 frnewline --> site away from the laboratory shall be placed in a closed durable leak-proof  <!-- PJG 0012 frnewline --> container prior to removal from the laboratory.  <!-- PJG 0012 frnewline --> Appendix Q-II-B&hyph;1-b-(2). Needles and syringes shall be promptly placed in a  <!-- PJG 0012 frnewline --> puncture-resistant container and decontaminated, preferably by autoclaving, before  <!-- PJG 0012 frnewline --> discard or reuse.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Appendix Q-II-B&hyph;1-c. Signs (BL2&hyph;N)  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix Q-II-B&hyph;1-c-(1). When the animal research requires special provisions  <!-- PJG 0012 frnewline --> for entry (e.g., vaccination), a warning sign incorporating the universal biosafety  <!-- PJG 0012 frnewline --> symbol shall be posted on all access doors to the animal work area. The sign shall  <!-- PJG 0012 frnewline --> indicate: (i) The agent, (ii) the animal species, (iii) the name and telephone  <!-- PJG 0012 frnewline --> number of the Animal Facility Director or other responsible individual, and (iv)  <!-- PJG 0012 frnewline --> any special requirements for entering the laboratory. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Appendix Q-II-B&hyph;1-d. Protective Clothing (BL2&hyph;N) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix Q-II-B&hyph;1-d-(1). Laboratory coats, gowns, smocks, or uniforms shall be  <!-- PJG 0012 frnewline --> worn while in the animal area or attached laboratory. Before entering non-laboratory areas (e.g., cafeteria, library, administrative offices), protective clothing  <!-- PJG 0012 frnewline --> shall be removed and kept in the work entrance area. <!-- PJG 0012 frnewline --> Appendix Q-II-B&hyph;1-d-(2). Special care shall be taken to avoid skin contamination  <!-- PJG 0012 frnewline --> with microorganisms containing recombinant DNA. Impervious and/or protective  <!-- PJG 0012 frnewline --> gloves shall be worn when handling experimental animals and when skin contact  <!-- PJG 0012 frnewline --> with an infectious agent is unavoidable. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Appendix Q-II-B&hyph;1-e. Records (BL2&hyph;N) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix Q-II-B&hyph;1-e-(1). Any incident involving spills and accidents that result in  <!-- PJG 0012 frnewline --> environmental release or exposures of animals or laboratory workers to organisms  <!-- PJG 0012 frnewline --> containing recombinant DNA molecules shall be reported immediately to the  <!-- PJG 0012 frnewline --> Animal Facility Director, Institutional Biosafety Committee, NIH/ORDA, and  <!-- PJG 0012 frnewline --> other appropriate authorities (if applicable). Reports to the NIH/ORDA shall be  <!-- PJG 0012 frnewline --> sent to the Office of Recombinant DNA Activities, National Institutes of Health,  <!-- PJG 0012 frnewline --> Building 31, Room 4B11, Bethesda, Maryland 20892, (301) 496&hyph;9838. Medical  <!-- PJG 0012 frnewline --> evaluation, surveillance, and treatment shall be provided as appropriate and  <!-- PJG 0012 frnewline --> written records maintained. If necessary, the area shall be appropriately  <!-- PJG 0012 frnewline --> decontaminated. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Appendix Q-II-B&hyph;1-e-(2). When appropriate and giving consideration to the agent  <!-- PJG 0012 frnewline --> handled, baseline serum samples shall be collected and stored for animal care and  <!-- PJG 0012 frnewline --> other at-risk personnel. Additional serum specimens may be collected periodically  <!-- PJG 0012 frnewline --> depending on the agent handled and the function of the animal facility. <!-- PJG 0012 frnewline --> Appendix Q-II-B&hyph;1-f. Transfer of Materials (BL2&hyph;N) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix Q-II-B&hyph;1-f-(1). Biological materials removed from the animal  <!-- PJG 0012 frnewline --> containment area in a viable or intact state shall be transferred to a non-breakable  <!-- PJG 0012 frnewline --> sealed primary container and then enclosed in a non-breakable sealed secondary  <!-- PJG 0012 frnewline --> container. All containers, primary and secondary, shall be disinfected before  <!-- PJG 0012 frnewline --> removal from the animal facility. Advance approval for transfer of material shall  <!-- PJG 0012 frnewline --> be obtained from the Animal Facility Director. Packages containing viable agents  <!-- PJG 0012 frnewline --> may only be opened in a facility having an equivalent or higher level of physical  <!-- PJG 0012 frnewline --> containment unless the agent is biologically inactivated or incapable of  <!-- PJG 0012 frnewline --> reproduction. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> Appendix Q-II-B&hyph;1-g. Other (BL2&hyph;N) <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix Q-II-B&hyph;1-g-(1). All genetically engineered neonates shall be  <!-- PJG 0012 frnewline --> permanently marked within 72 hours after birth, if their size permits. If their size  <!-- PJG 0012 frnewline --> does not permit marking, their containers should be marked. In addition,  <!-- PJG 0012 frnewline --> transgenic animals should contain distinct and biochemically assayable DNA  <!-- PJG 0012 frnewline --> sequences that allow identification of transgenic animals from among non-transgenic animals.  <!-- PJG 0012 frnewline --> Appendix Q-II-B&hyph;1-g-(2). Needles and syringes shall be used only for parenteral  <!-- PJG 0012 frnewline --> injection and aspiration of fluids from laboratory animals and diaphragm bottles.  <!-- PJG 0012 frnewline --> Only needle-locking syringes or disposable syringe-needle units (i.e., needle is  <!-- PJG 0012 frnewline --> integral to the syringe) shall be used for the injection or aspiration of fluids  <!-- PJG 0012 frnewline --> containing organisms that contain recombinant DNA. Extreme caution shall be  <!-- PJG 0012 frnewline --> used when handling needles and syringes to avoid autoinoculation and the  <!-- PJG 0012 frnewline --> generation of aerosols during use and disposal. Following use, needles shall not be  <!-- PJG 0012 frnewline --> bent, sheared, replaced in the needle sheath or guard, or removed from the  <!-- PJG 0012 frnewline --> syringe. Needles and syringes shall be promptly placed in a puncture-resistant  <!-- PJG 0012 frnewline --> container and decontaminated, preferably by autoclaving, before discard or reuse.  <!-- PJG 0012 frnewline --> Appendix Q-II-B&hyph;1-g-(3). Appropriate steps should be taken to prevent horizontal  <!-- PJG 0012 frnewline --> transmission or exposure of laboratory personnel. If the agent used as a vector is  <!-- PJG 0012 frnewline --> known to be transmitted by a particular route (e.g., arthropods), special attention  <!-- PJG 0012 frnewline --> should be given to preventing spread by that route. In the absence of specific  <!-- PJG 0012 frnewline --> knowledge of a particular route of transmission, all potential means of horizontal  <!-- PJG 0012 frnewline --> transmission (e.g., arthropods, contaminated bedding, or animal waste, etc.) should  <!-- PJG 0012 frnewline --> be prevented.  <!-- PJG 0012 frnewline --> Appendix Q-II-B&hyph;1-g-(4). Eating, drinking, smoking, and applying cosmetics shall  <!-- PJG 0012 frnewline --> not be permitted in the work area.  <!-- PJG 0012 frnewline --> Appendix Q-II-B&hyph;1-g-(5). Individuals who handle materials and animals containing  <!-- PJG 0012 frnewline --> recombinant DNA molecules shall be required to wash their hands before exiting  <!-- PJG 0012 frnewline --> the containment area.  <!-- PJG 0012 frnewline --> Appendix Q-II-B&hyph;1-g-(6). A double barrier shall be provided to separate male and  <!-- PJG 0012 frnewline --> female animals unless reproductive studies are part of the experiment or other  <!-- PJG 0012 frnewline --> measures are taken to avoid reproductive transmission. Reproductive  <!-- PJG 0012 frnewline --> incapacitation may be used.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            